Previous studies have demonstrated that lifestyle interventions, principally dietary modification and regular exercise, are the cornerstones of NAFLD treatment.19,20 In addition, it has been suggested that peroxisome proliferator-activated receptor (PPAR) agonists ameliorate metabolic disorders, inflammation, and OS related to NAFLD. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.